Severe COVID-19 Disables Disease-Fighting Immune Circuit
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
University of California San Francisco
Displaying 1651 - 1680 of 16427
-
-
The Inside Story of How the Bay Area Coronavirus Variant Was Discovered
-
Comprehensive Parnassus Heights Plan Moves Forward After UC Regents Vote
The Regents’ vote follows more than two years of robust community engagement spanning 28 public meetings to develop the CPHP, which reflects input from hundreds of stakeholders inside and outside UCSF.
-
UCSF Experts Among Highlights at 2021 Precision Medicine World Conference Focused on COVID-19
Scientific presentations will include advances in understanding the immune response, and precision medicine-driven development of new diagnostics, therapeutics, vaccines, and population health strategies.
-
COVID-19 Predictions for 2021 and Beyond
Few would have predicted last January that a pandemic would upend our daily lives. But one grueling year in, UCSF experts have a clearer view of the path ahead.
-
COVID-19 Variant First Found in Other Countries and States Now Seen More Frequently in California
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
-
Personalized Brain Stimulation Alleviates Severe Depression Symptoms
Depression is among the most common psychiatric disorders, affecting as many as 264 million people worldwide and leading to hundreds of thousands of deaths per year. But as many as 30 percent of patients do not respond to standard treatments such as medication or psychotherapy.
-
Community Workforce Agreement for Parnassus Project is Boon for Local Jobs, Economy
UCSF, the San Francisco Building and Construction Trades Council, and Herrero Boldt Webcor have announced a Community Workforce Agreement that will promote collaboration between the University, labor unions and construction firms during the construction of the new hospital at UCSF Helen Diller Medical Center at Parnassus Heights.
-
Is the COVID Vaccine Less Effective in Older Adults, and Should I Worry About Which One I Get?
-
Virus Versus Virus: ‘ReScan’ Antibody Test is a Powerful New Tool
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
-
How Worried Should You Be About the New Coronavirus Variant?
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
-
Career Office-Alum Collaboration Yields $2.3M Award
-
Brain Cells Most Vulnerable to Alzheimer’s Disease Identified by Scientists
A team of researchers has identified for the first time the neurons that are among the first victims of Alzheimer’s disease.
-
UCSF Administers Second Dose of COVID-19 Vaccine to Frontline Staff
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work.
-
Health Expert Proposes Distributing Vaccine by Lottery
-
How Fast Can Scientists Find the New Coronavirus Strains?
-
Will Kids Be Safe When They Return to School? Will Everyone Else?
A UCSF pediatrician who is researching methods to control the spread of coronavirus shares why she’s optimistic that schools can reopen safely.
-
‘Invisible’ Stem Cells Evade Natural Killer Cells Using Immune ‘Off-Switch’
UCSF scientists have discovered a new way to control the immune system’s “natural killer” cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection.
-
Cancer Metastasis is Target of New Research Initiative
A new research collaborative at UCSF will be focused on decoding the “rulebook” of metastatic cancer as a pathway to new treatments.
-
Seniors Living Alone with Cognitive Impairment Hit Hard by COVID-19 Pandemic
Researchersare calling for tailored services and support for older adults living alone with memory issues, who are experiencing extreme isolation, and are exposed to misinformation about the virus and barriers to accessing medical care.
-
Why CO2 Monitors and Indoor Ventilation May Be a Key to Curb COVID Spread
-
Julius Schachter, Leading Expert on Chlamydia, Dies at 84
-
Expansive Community Investments to Accompany Parnassus Heights Campus Plans
UCSF and the City and County of San Francisco have announced an agreement in principle on a set of community benefits to accompany the University’s Comprehensive Parnassus Heights Plan to modernize its historic campus.
-
Frailty Is a Factor in Higher Mortality for Women Awaiting Liver Transplants
A study headed by UCSF and Columbia University highlights the role that frailty plays in this gender gap.
-
With Musical Life on Hiatus, a Horn Virtuoso Tackles the COVID Pandemic
-
Explanations for ‘Long COVID’ Remain Elusive. For Now, Believing Patients and Treating Symptoms Is the Best Doctors Can Do
-
How Stanford’s Vaccine Algorithm Caused a Major Controversy and Left Frontline Workers at the Back of the Line
-
Allergic Reactions to the Coronavirus Vaccine: Should I Be Concerned?
-
UCSF and BridgeBio Pharma to Accelerate Therapies for Genetic Diseases
UCSF and BridgeBio Pharma, Inc. today announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients.
-
E-Cigarettes, as Consumer Products, Do Not Help People Quit Smoking, Study Finds
A team led by UCSF’s Richard Wang, surveyed the scientific community’s understanding of e-cigarettes and found that, in the form of mass-marketed consumer products, they do not lead smokers to quit.
